Clinical Pharmacology & Biopharmaceutics
Open Access

Priyamvada Chandra

DMPK, Novartis Institutes for BioMedical Research (NIBR), East Hanover, NJ, USA

Biography

Priyamvada Chandra is affiliated to DMPK, Novartis Institutes for BioMedical Research (NIBR), East Hanover, NJ, USA. She is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. Her international experience includes various programs, contributions and participation in different countries for diverse fields of study. Her research interests reflect in his wide range of publications in various national and international journals.

Publications

Assessment of Drug Interaction Potential between LCZ696, an Angiotensin Receptor Neprilysin Inhibitor, and Digoxin or Warfa rin

LCZ696 (sacubitril/valsartan) is a first-in-class angiotensin receptor neprilysin inhibitor that simultaneously inhibits neprilysin and blocks the angiotensin II receptor. LCZ696 has been recently approved for treatment of HF and likely be co-administered with digoxin or warfarin. The drug interaction potential between LCZ696 and digoxin or warfari... Read More»

Surya Ayalasomayajula, Pierre Jordaan, Parasar Pal, Priyamvada Chandra, Diego Albrecht, Thomas Langenickel, Iris Rajman and Gangadhar Sunkara

Research Article: Clin Pharmacol Biopharm 2015, 4:147

DOI: 10.4172/2167-065X.1000147

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF